Other News

Sirtex Medical and BlackSwan Vascular, Inc. announce first patient enrolled in pivotal LAVA Study

LAVA clinical trial underway for potential first FDA-approved liquid embolic system for a peripheral vascular indication WOBURN, Mass., April 19, 2021 /PRNewswire/ — Sirtex Medical (Sirtex), a leading manufacturer of targeted liver cancer therapies, and BlackSwan Vascular, Inc. (BlackSwan), a Bay Area-based private company developing groundbreaking therapies in endovascular embolization, announced that the first […]

Vaica to Offer Anticoagulation Medication Adherence & Monitoring solution

TEL AVIV, Israel, April 19, 2021 /PRNewswire/ — Vaica™ Medical, an innovation leading provider in medication adherence and remote patient management (RPM) is announcing its anti-coagulation (blood clotting) remote management solution. The need to maintain an optimal blood viscosity levels is pertinent for at-risk patients with Thrombotic Predisposition (hypercoagulable states), heart rhythm disorders, […]

Philips installs leading digital imaging solutions at new Central Acute Services Building of Westmead Hospital in Sydney Australia

April 19, 2021 New state-of-the-art Central Acute Services Building at Westmead Hospital features next-generation diagnostic and neurovascular imaging solutions, aimed at improving the efficiency and accuracy of care delivered to trauma patients requiring critical care Installation of first Philips Magnetic Resonance – Ingenia MR-OR – intraoperative systems in Australia and […]

Neovasc Comments on EuroIntervention Article

VANCOUVER and MINNEAPOLIS, April 19, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that the journal EuroIntervention has published an article entitled, “Coronary Sinus Reducer Implantation Results in Improved Oxygen Kinetics at Cardiopulmonary Exercise Test in Patients with Refractory Angina.” The article, authored by Carlo Zivelonghi, M.D., Antwerp […]

Canon Medical Receives FDA Clearance on One-Beat Spectral Cardiac CT

Aquilion ONE / PRISM Edition Now Offers AI Powered Spectral Capabilities for Cardiac Exams TUSTIN, Calif.–(BUSINESS WIRE)–Meeting the growing cardiovascular needs of healthcare providers today, Canon Medical Systems USA, Inc. announces that its Deep Learning Spectral CT has received 510(k) clearance for expanded capabilities into cardiovascular applications. Available on the company’s Aquilion ONE […]

LivaNova Achieves Clinical Milestone in Heart Failure Program

300th patient randomized in ANTHEM-HFrEF pivotal study LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it has randomized the 300th patient in the Autonomic Regulation Therapy to Enhance Myocardial Function and Reduce Progression of Heart Failure With Reduced Ejection Fraction (ANTHEM-HFrEF) Pivotal Study, which was approved by the U.S. Food and Drug Administration (FDA) […]

Ziehm Imaging Americas and Carestream Announce Partnership To Distribute the Ziehm Vision RFD

ROCHESTER, N.Y. & SCOTTSDALE, Ariz.–(BUSINESS WIRE)–In partnership with Ziehm Imaging, Carestream Health is pleased to announce the addition of a mobile C-arm into its growing innovative product portfolio. Known as the Ziehm Vision RFD C-arm, this surgical imaging system will further enhance Carestream’s mobile and fluoroscopic product offerings to benefit even more healthcare […]

Elucid Presents Results of the EVAPORATE Study at ESC Preventive Cardiology 2021 Late Breakers

Elucid Software Quantifies Plaque Morphology to Enable Better Assessment of IPE Treatment Effects BOSTON–(BUSINESS WIRE)–Elucid, a medical technology company developing AI software for physicians to optimize the treatment of patients with known or suspected vascular disease, announced that first author and Elucid founder Andrew Buckler presented findings today from the […]

Neovasc Provides Tiara TA Update

VANCOUVER and MINNEAPOLIS, April 16, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), today announced that the Tiara Transapical system (“Tiara TA”) will be unable to receive a European CE mark under the current Medical Device Directive regulations (“MDD”) ending on May 26, 2021. The Company is […]